These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10798185)

  • 21. [Anaphylaxis due to drugs].
    Suzuki I
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():313-7. PubMed ID: 18074554
    [No Abstract]   [Full Text] [Related]  

  • 22. [Allergy to radiographic contrast media].
    Vionnet J; Petitpierre S; Fumeaux A; Meuli R; Spertini F; Comte D
    Rev Med Suisse; 2013 Apr; 9(382):812-8. PubMed ID: 23667970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis, prevention and treatment of drug allergy].
    Patkowski J; Małolepszy J; Ciepichał J
    Postepy Hig Med Dosw; 1987; 41(1):45-53. PubMed ID: 3299343
    [No Abstract]   [Full Text] [Related]  

  • 24. Prekallikrein-Kallikrein conversion rate as a predictor of contrast material catastrophies.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE; Howard MM
    Radiology; 1981 Jul; 140(1):11-5. PubMed ID: 6166025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hypersensitivity reactions to iodinated contrast media.
    Brockow K; Christiansen C; Kanny G; Clément O; Barbaud A; Bircher A; Dewachter P; Guéant JL; Rodriguez Guéant RM; Mouton-Faivre C; Ring J; Romano A; Sainte-Laudy J; Demoly P; Pichler WJ; ;
    Allergy; 2005 Feb; 60(2):150-8. PubMed ID: 15647034
    [No Abstract]   [Full Text] [Related]  

  • 26. Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock.
    Kim MH; Lee SY; Lee SE; Yang MS; Jung JW; Park CM; Lee W; Cho SH; Kang HR
    PLoS One; 2014; 9(6):e100154. PubMed ID: 24932635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent anaphylaxis to a gelatin-based colloid plasma substitute and to cetuximab following sensitisation to galactose-alpha-1,3-galactose.
    Serrier J; Khoy K; Ollivier Y; Gervais R; Le Moel G; Lafosse M; Johnson A; Le Mauff B; Mariotte D
    Br J Anaesth; 2021 Jun; 126(6):e200-e202. PubMed ID: 33810867
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial: New Insights In Anaphylaxis.
    Pastor-Vargas C; Esteban V
    Front Immunol; 2018; 9():506. PubMed ID: 29593740
    [No Abstract]   [Full Text] [Related]  

  • 29. Contrast reaction.
    Brege DJ
    Nursing; 2008 Mar; 38(3):72. PubMed ID: 18418195
    [No Abstract]   [Full Text] [Related]  

  • 30. Peri-operative anaphylaxis.
    Nel L; Eren E
    Br J Clin Pharmacol; 2011 May; 71(5):647-58. PubMed ID: 21235622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug induced emergencies.
    Kapadia FN
    J Assoc Physicians India; 1995 Apr; 43(4):269-72. PubMed ID: 8713268
    [No Abstract]   [Full Text] [Related]  

  • 32. [Allergy to iodinated drugs and to foods rich in iodine: Iodine is not the allergenic determinant].
    Dewachter P; Mouton-Faivre C
    Presse Med; 2015 Nov; 44(11):1136-45. PubMed ID: 26387623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period.
    Kvedariene V; Martins P; Rouanet L; Demoly P
    Clin Exp Allergy; 2006 Aug; 36(8):1072-7. PubMed ID: 16911363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beware of the dog: a case report on cardiac involvement in drug allergy.
    Tosoni C; Cinquini M; Gretter V; Minetti S; Rizzini FL
    J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):686-8. PubMed ID: 20671566
    [No Abstract]   [Full Text] [Related]  

  • 35. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity.
    Torres MJ; Trautmann A; Böhm I; Scherer K; Barbaud A; Bavbek S; Bonadonna P; Cernadas JR; Chiriac AM; Gaeta F; Gimenez-Arnau AM; Kang HR; Moreno E; Brockow K
    Allergy; 2021 May; 76(5):1325-1339. PubMed ID: 33170954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of anaphylactic/anaphylactoid reactions.
    Levy JH; Levi R
    Monogr Allergy; 1992; 30():130-44. PubMed ID: 1280764
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective desensitization to imiglucerase in a patient with type I Gaucher disease.
    Peroni DG; Pescollderungg L; Piacentini GL; Cassar W; Boner AL
    J Pediatr; 2009 Dec; 155(6):940-1. PubMed ID: 19914435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia: some diagnostic issues.
    Ebo DG; Hagendorens MM; Bridts CH; De Clerck LS; Stevens WJ
    Acta Anaesthesiol Scand; 2008 Feb; 52(2):314-5. PubMed ID: 18201317
    [No Abstract]   [Full Text] [Related]  

  • 39. Report of a symposium: adverse responses to intravenous agents.
    Watkins J; Clarke RS
    Br J Anaesth; 1978 Nov; 50(11):1159-64. PubMed ID: 718787
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaphylaxis - identification, management and prevention.
    Laemmle-Ruff I; O'Hehir R; Ackland M; Tang ML
    Aust Fam Physician; 2013; 42(1-2):38-42. PubMed ID: 23529459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.